期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

脑海绵状血管畸形的病因学研究进展

下载PDF
导出
摘要 脑海绵状血管畸形（cerebral cavernous malfor-mation，CCM）是指由众多薄壁血管组成的海绵状异常血管团，这些畸形血管紧密相贴，血管间没有或极少有脑实质组织。过去认为CCM少见，发病率为0．02％-0．53％。近几年来随着MRI的应用，CCM发生率有所增加，与尸检报道相仿，占脑血管畸形的5％～13％。
作者 刘必松 王如密 杨朋范
机构地区 南京军区福州总医院神经外科
出处 《中国临床神经外科杂志》 2009年第6期375-378,共4页 Chinese Journal of Clinical Neurosurgery
关键词 脑海绵状血管畸形 脑血管畸形 病因学 研究进展
分类号 R743.4 [医药卫生—神经病学与精神病学]
  • 相关文献

参考文献20

  • 1Battistini S, Rocchi R, Cerase A, et al . Clinical, magnetic resonance imaging, and genetic study of 5 Italian families with cerebral cavernous malformation [J]. Arch Neurol, 2007, 64: 843-848.
  • 2Lucas M, Costa AF, Montori M, et al . Germline mutations in the CCM1 gene, encoding Kritl, cause cerebral cavernous malformations [J]. Ann Neurol, 2001, 49: 529-532.
  • 3Gunel M, Laurans MS, Shin D, et al. KRIT1, a gene mutated in cerebral cavernous malformation, encodes a microtubule-associated protein [J]. Proc Natl Acad Sci USA, 2002, 99: 10677-10682.
  • 4Zawistowski JS , Serebriiskii IG , Lee MF, et ol . KRIT1 association with the integrin-binding protein ICAP-1: a new direction in the elucidation of cerebral cavernous malformations (CCM1) pathogenesis [J]. Hum Mol Genet, 2002, 11: 389-396.
  • 5Seker A, Prieola KL, Guclu B, et al . CCM2 expression parallels that of CCMI [J]. Stroke, 2006, 37: 518N523.
  • 6McCarty JH, Lacy-Hulbert A, Charest A, et al . Selective ablation of alpha vintegrins in the central nervous system leads to cerebral hemorrhage, seizures, axonal degeneration and premature death [J]. Development, 2005, 132: 165-176.
  • 7Bergametti F, Denier C, Labauge P, et al . Mutations within the programmed cell death 10 gene cause cerebral cavernous malformations [J]. Am J Hum Genet, 2005, 76: 42-51.
  • 8Wang YG, Liu HT, Zhang YM, et al . cDNA cloning and expression of an apoptosis-related gene, human TFAR15 gene [J]. Sci China Ser C: Life Sci, 1999, 4(3): 101-107.
  • 9Ma X, Zhao H, Shan J, et al . PDCD10 interacts with Ste20-related kinase MST4 to promote cell growth and transformation via modulation of the ERK pathway [J]. Mol Biol Cell, 2007, 18: 1965-1978.
  • 10Ciricillo SF, Cogen PH, Edwards MS. Pediatric cryptic vascular malformations: presentation, diagnosis and treatment [J]. Pediatr Neurosurg, 1994, 20: 137-147.

二级参考文献13

  • 1Sato TN, Tozawa Y ,Deutsch U,et al. Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation. Nature,1995,376:70-74.
  • 2Stratmann A, Risan W, Plate KH. Cell type-specific expression of angiopoietin-1 and angiopoietin-2 suggests a role in glioblastoma angiogenesis. Am J Pathol, 1998,153:1459-1466.
  • 3Uranish R, Baev NI, Ng PY, et al. Expression of endothelial cell argiogenesis receptors in human cerebrovascalw malformations. Neurosurg, 2001,48: 359-368.
  • 4Brown LF,Detmar IN, Claffey K, et al. Vascular Permeability factor/vascular endothelial growth factt: a multifunctional angiogenic cvtokine. EXS, 1997,79: 233-269.
  • 5Neufeld G, Cohen T, Gengrinovitch S, et al. Vascular erdothla/growth fact(VEGF) and its receptors. FASEBJ, 1999,13: 9-22.
  • 6Shalaby F, Ho J, Stanford WL, et al. A requirement for Flk-1 in primitive and definitive hematopoiesis and vasculogenesis. Cell,1997,89: 981-990.
  • 7Shalaby F, Rosssnt J, Yamaguchi TP, et al. Failure of blood-island formation and Vasculogenesis in Flk-1-deficient mice. Nature, 1995,376: 62-66.
  • 8Maisonpierre PC, Suri C, Jones PF, et al. Angiopoietin-2, a natural antagonist for Tie-2 that disrupts in vivo angiogenesis. Science,1997,277: 55-60.
  • 9Moyiarity JL, Clatterbuck RE, Rigamomti D. The natural history of cavernous malformations. Neurosurgery Clinics of North America,1999: 411-417.
  • 10Ferrara N, Herzel WJ. Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells.Biochem Biophys Res Co mmun, 1989,161:851-855.

共引文献3

中国临床神经外科杂志
2009年 第6期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部